ReviewTherapeutic advances in musculoskeletal disease2020

Tuberculosis and targeted synthetic or biologic DMARDs, beyond tumor necrosis factor inhibitors.

Gerasimos Evangelatos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.